Association of Dietary Flavonoids Intake With All‐Cause and Cardiovascular Disease Mortality in Diabetic Kidney Disease: A Cohort Study From the NHANES Database

Qian Wang, Weizhu Deng, Jian Yang, Yaqing Li, Hui Huang, Yayong Luo, Zhongxia Li, Zheyi DongJournal of Diabetes Research 2024 · DOI

TL;DR

This study investigated the link between dietary flavonoid intake and mortality in individuals with diabetic kidney disease (DKD). They found that higher flavonoid intake, particularly from flavones and anthocyanidins, was associated with a reduced risk of both all-cause and cardiovascular disease (CVD) mortality in this high-risk population. This suggests that dietary interventions focusing on flavonoids could be a promising strategy to improve outcomes for DKD patients.

What Problem Does This Paper Address?

Diabetic kidney disease (DKD) is a serious complication of diabetes that significantly increases the risk of mortality. Despite advancements in management, DKD patients still face a considerably higher mortality rate compared to the general population or those with diabetes but without kidney complications. While dietary modifications are known to be beneficial, the specific impact of dietary compounds like flavonoids on mortality outcomes in DKD patients has remained largely unexplored. This paper aims to fill that knowledge gap by examining whether consuming more flavonoids can help reduce the risk of death in individuals with DKD.

Methods

The researchers utilized a retrospective cohort study design, drawing data from the National Health and Nutrition Examination Survey (NHANES) for the years 2007-2010 and 2017-2018. They identified participants with DKD based on established criteria for diabetes and chronic kidney disease (CKD). Dietary flavonoid intake was assessed using two 24-hour dietary recall interviews, capturing both total flavonoid intake and intake of six specific subclasses: flavones, flavan-3-ols, anthocyanidins, flavanones, flavonols, and isoflavones. Survival status was tracked by linking participants to the National Death Index up to December 31, 2019.

To analyze the association between flavonoid intake and mortality, they employed Kaplan-Meier curves for survival analysis and weighted Cox proportional hazard regression models. These models were crucial for estimating hazard ratios (HR) and their 95% confidence intervals (CI), while also adjusting for a comprehensive set of potential confounding factors, including demographics, lifestyle choices, and other health conditions.

Datasets

The primary dataset used in this study was the National Health and Nutrition Examination Survey (NHANES), specifically data from the 2007-2008, 2009-2010, and 2017-2018 survey cycles. This is a well-established, nationally representative health survey in the United States.

The survival status of participants was determined by linking to the National Death Index (NDI), a centralized database maintained by the NCHS that records all deaths in the United States.

The study also utilized the Food and Nutrient Database for Dietary Studies (FNDDS) to assess dietary flavonoid intake.

No new datasets or benchmarks were introduced by this study.

Key Insights and Ideas

  • Flavonoids as a Protective Factor in DKD: The study strongly suggests that dietary flavonoids are not just beneficial for general health but may play a specific, protective role in mitigating mortality risk for individuals already diagnosed with DKD. This is a critical finding given the high mortality associated with this condition.
  • Specific Subclasses Matter: It's not just about "eating more plants"; the study highlights that certain subclasses of flavonoids, particularly flavones and anthocyanidins, show a more pronounced association with reduced mortality. This points towards targeted dietary recommendations.
  • Dual Benefit: All-Cause and CVD Mortality: The protective effect extends to both general mortality (all-cause) and the more specific, and often fatal, cardiovascular disease mortality. This indicates a broad impact on health and longevity.
  • Potential for Dietary Intervention: The findings open the door for practical dietary interventions. If higher flavonoid intake can significantly reduce mortality risk, then encouraging consumption of flavonoid-rich foods could become a key component of DKD management.

Key Results

  • A total of 1155 DKD patients were included in the analysis.
  • After a median follow-up of 76.36 months, 409 participants died of all-cause mortality, and 138 died of CVD mortality.
  • In the fully adjusted model, higher total dietary flavonoid intake was associated with a reduced risk of all-cause mortality (HR = 0.69, 95% CI: 0.52-0.92).
  • Higher intake of flavones was associated with lower all-cause mortality (HR = 0.60, 95% CI: 0.35-0.85).
  • For CVD mortality, higher intake of anthocyanidins (HR = 0.54, 95% CI: 0.28-0.87) and flavones (HR = 0.50, 95% CI: 0.28-0.87) were significantly associated with lower odds.
  • Further subgroup analyses indicated that higher flavone and luteolin intake were associated with decreased CVD mortality, particularly in smokers and individuals with BMI ≥ 25 kg/m².

Limitations and Future Work

The authors acknowledge several limitations:

  • Dietary Assessment Method: The reliance on 24-hour dietary recalls, while standard, can be subject to self-report bias and may not perfectly capture long-term dietary habits.
  • Cross-Sectional Nature of Intake: Flavonoid intake was assessed at a single point in time (baseline), meaning changes in diet over the follow-up period were not captured. This limits the ability to establish causality definitively.
  • Generalizability: The study population is from the US, and findings may not be directly generalizable to other populations with different dietary patterns or genetic backgrounds.

The authors suggest that future research should focus on:

  • Elucidating Mechanisms: Further investigation is needed to understand the specific biological pathways through which flavonoids exert their protective effects in DKD patients, such as their antioxidant and anti-inflammatory properties.
  • Interventional Studies: Randomized controlled trials are necessary to confirm these observational findings and to establish the efficacy of flavonoid-focused dietary interventions for improving outcomes in DKD.
  • Increasing Awareness: Educating healthcare professionals about the benefits of flavonoids is crucial to facilitate timely interventions and personalized treatment plans for DKD patients.

Summary updated

Abstract

The relationship between dietary flavonoid intake and mortality in the diabetic kidney disease (DKD) population is unknown. So this study is aimed at investigating the association of total dietary flavonoid intake and their subclasses with all-cause and cardiovascular disease (CVD) mortality. Data of this cohort study were extracted from the NHANES (2007-2010 and 2017-2018). The survival status of participants was determined by linking to the National Death Index through the end of 2019. Flavonoid intake was measured using two 24-h dietary recall interviews. The Kaplan-Meier curves and weighted Cox proportional hazard regression models were used to assess the effect of dietary flavonoid intake on CVD and all-cause mortality, with adjustments for multiple covariates. A total of 1155 participants were included for analysis. After a median follow-up of 76.36 (S.E: 3.24) months, 409 participants died of all-cause mortality, of which 138 died of CVD. In the fully adjusted model, higher total dietary flavonoids intake (HR = 0.69, 95% CI: 0.52-0.92) was associated with lower all-cause mortality and subclasses of higher flavones (HR = 0.60, 95% CI: 0.35-0.85) was also with lower all-cause mortality. In subclasses of flavonoids, higher intake of both anthocyanidins (HR = 0.54, 95% CI: 0.28 to 0.87) and flavones (HR = 0.50, 95% CI: 0.28-0.87) were associated with lower odds of CVD mortality. Higher flavonoid intake was associated with a reduced risk of CVD and all-cause mortality in DKD. Higher flavonoid intake provides a potential opportunity to improve the prognosis of DKD. And future research into the mechanisms between flavonoids and mortality is needed.
BibTeX
@article{wang2024association,
  author = {Qian Wang and Weizhu Deng and Jian Yang and Yaqing Li and Hui Huang and Yayong Luo and Zhongxia Li and Zheyi Dong},
  title = {{Association of Dietary Flavonoids Intake With All‐Cause and Cardiovascular Disease Mortality in Diabetic Kidney Disease: A Cohort Study From the NHANES Database}},
  journal = {Journal of Diabetes Research},
  year = {2024},
  doi = {10.1155/2024/8359294},
}
Figure